Cargando…

Pembrolizumab and tavokinogene telseplasmid electroporation in metastatic melanoma

INTRODUCTION: Tavokinogene Telseplasmid Electroporation Therapy (TAVO) and Pembrolizumab therapy is being studied in subjects with immune checkpoint inhibitor (ICI) resistant melanoma. TAVO is a novel office-based local therapy shown to be effective in patients with advanced melanoma. The technique...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dollin, Yonatan, Rubin, Jason, Carvajal, Richard D., Rached, Helene, Nitzkorski, James R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7708754/ https://www.ncbi.nlm.nih.gov/pubmed/33395852 http://dx.doi.org/10.1016/j.ijscr.2020.11.063

Ejemplares similares

Disease stabilization with pembrolizumab for metastatic acral melanoma in the setting of autoimmune bullous pemphigoid
por: Beck, Kristen M., et al.
Publicado: (2016)

Disseminated blastomycosis in a patient on pembrolizumab for metastatic melanoma
por: Ferguson, Ian, et al.
Publicado: (2019)

Cutaneous CD56(+) T-cell lymphoma developing during pembrolizumab treatment for metastatic melanoma
por: Zheng, Yixuan James, et al.
Publicado: (2018)

AIHA and Pancytopenia as Complications of Pembrolizumab Therapy for Metastatic Melanoma: A Case Report
por: Ni, Dan, et al.
Publicado: (2019)

Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission
por: Satish, Tejus, et al.
Publicado: (2021)

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma
por: Läubli, Heinz, et al.
Publicado: (2015)

Organizing pneumonia following treatment with pembrolizumab for metastatic malignant melanoma – A case report
por: Kuint, R., et al.
Publicado: (2017)

Metastatic melanoma with features of blue nevus and tumoral melanosis identified during pembrolizumab therapy
por: Helm, Matthew F., et al.
Publicado: (2017)

Pityriasis lichenoides chronica–like drug eruption developing during pembrolizumab treatment for metastatic melanoma
por: Mutgi, Krishna A.J., et al.
Publicado: (2016)

A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
por: Wu, Lili, et al.
Publicado: (2021)

Immune-related acute and lymphocytic gastritis in a patient with metastatic melanoma treated with pembrolizumab immunotherapy
por: Gaffuri, P., et al.
Publicado: (2019)

Pembrolizumab: First in Class for Treatment of Metastatic Melanoma
por: Barnhart, Carrie
Publicado: (2015)

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report
por: Lambert, Ine, et al.
Publicado: (2021)

The Tale of a Double-Edged Sword: Protecting the Heart from Metastatic Melanoma Tumor and its Treatment with Pembrolizumab
por: Suero-Abreu, Giselle A., et al.
Publicado: (2019)

Efficacy of pembrolizumab rechallenge for metastatic urothelial carcinoma
por: Nishimura, Nobutaka, et al.
Publicado: (2022)

Remission of a Perimyocardial Melanoma Metastasis With Pembrolizumab Treatment
por: Larsen, Frederik Uttenthal, et al.
Publicado: (2019)

Pembrolizumab as first-line treatment for metastatic uveal melanoma
por: Rossi, Ernesto, et al.
Publicado: (2019)

Tumoral Melanosis Associated with Pembrolizumab-Treated Metastatic Melanoma
por: Bari, Omar, et al.
Publicado: (2017)

Multiregional genetic evolution of metastatic uveal melanoma
por: Rodriguez, Daniel A., et al.
Publicado: (2021)

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
por: Cortellini, Alessio, et al.
Publicado: (2018)

Pembrolizumab for Refractory Metastatic Myxofibrosarcoma: A Case Report
por: Song, Haa-Na, et al.
Publicado: (2018)

Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma
por: Cucu, Corina Ioana, et al.
Publicado: (2021)

Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report
por: Kwatra, Vineet, et al.
Publicado: (2017)

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
por: Muralikrishnan, Sivraj, et al.
Publicado: (2020)

Lichen planopilaris associated with pembrolizumab in a patient with metastatic melanoma
por: Cogen, Anna L., et al.
Publicado: (2018)

Efficacy of pembrolizumab for advanced/metastatic melanoma: a meta-analysis
por: Zhang, Qi, et al.
Publicado: (2020)

An extrauterine extensively metastatic epithelioid trophoblastic tumor responsive to pembrolizumab
por: Bell, Sarah G., et al.
Publicado: (2021)

Vitiligoid hypopigmentation associated with pembrolizumab in metastatic head and neck cancer
por: Bulbul, Ajaz
Publicado: (2019)

“Giant cell arteritis manifesting as retinal arterial occlusion and paracentral acute middle maculopathy in a patient on pembrolizumab for metastatic uveal melanoma”
por: Narala, Ramsudha, et al.
Publicado: (2020)

Successful administration of sequential TVEC and pembrolizumab followed by Temozolomide in immunotherapy refractory intracranial metastatic melanoma with acquired B2M mutation
por: Khaddour, Karam, et al.
Publicado: (2020)

Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab
por: Zibelman, Matthew, et al.
Publicado: (2016)

Keratoacanthoma-appearing melanoma metastases in a patient receiving pembrolizumab therapy
por: Schopper, Heather, et al.
Publicado: (2016)

Polyendocrinopathy Resulting From Pembrolizumab in a Patient With a Malignant Melanoma
por: Paepegaey, Anne-Cécile, et al.
Publicado: (2017)

Pembrolizumab-Induced Fatal Myasthenia, Myocarditis, and Myositis in a Patient with Metastatic Melanoma: Autopsy, Histological, and Immunohistochemical Findings—A Case Report and Literature Review
por: Giovannini, Elena, et al.
Publicado: (2023)

Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
por: Zibetti Dal Molin, Graziela, et al.
Publicado: (2018)

Near complete response to Pembrolizumab in microsatellite-stable metastatic sebaceous carcinoma
por: Domingo-Musibay, Evidio, et al.
Publicado: (2018)

Pembrolizumab treatment of metastatic urothelial cancer without exacerbating myasthenia gravis
por: Ishii, Akiko, et al.
Publicado: (2020)

Complete Radiological Response of Recurrent Metastatic Adrenocortical Carcinoma to Pembrolizumab and Mitotane
por: Alam, Walid, et al.
Publicado: (2021)

Successful treatment of metastatic bladder pleomorphic giant cell carcinoma with pembrolizumab
por: Nezu, Kunihisa, et al.
Publicado: (2021)

Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm
por: Tsur, Neta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_98l2uc5c4pris2iq7gl9ctf1ok